0001225208-16-042819.txt : 20161206
0001225208-16-042819.hdr.sgml : 20161206
20161206195211
ACCESSION NUMBER: 0001225208-16-042819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161205
FILED AS OF DATE: 20161206
DATE AS OF CHANGE: 20161206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WANG HUIMIN
CENTRAL INDEX KEY: 0001204553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 162037428
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
4
1
doc4.xml
X0306
4
2016-12-05
0001099800
Edwards Lifesciences Corp
EW
0001204553
WANG HUIMIN
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, Japan & Intercontinental
Common Stock
2016-12-05
4
M
0
13650.0000
44.6150
A
89441.5748
D
Common Stock
2016-12-05
4
S
0
13650.0000
83.5347
D
75791.5748
D
Employee Stock Option (Right to Acquire)
44.6150
2016-12-05
4
M
0
13650.0000
0.0000
D
2012-05-12
2018-05-11
Common Stock
13650.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2016.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $83.10 to $83.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Ifigenia Protopappas, Attorney-in-fact
2016-12-06